Maverick Medichain Profile
Key Indicators
- Authorised Capital ₹ 6.55 Cr
as on 17-12-2024
- Paid Up Capital ₹ 5.47 Cr
as on 17-12-2024
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Revenue 1.63%
(FY 2021)
- Profit 5.10%
(FY 2021)
- Ebitda 3.41%
(FY 2021)
- Net Worth 0.57%
(FY 2021)
- Total Assets 0.55%
(FY 2021)
About Maverick Medichain
The Corporate was formerly known as Maverick Medicare Solutions Limited. The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 6.55 Cr and a paid-up capital of Rs 5.47 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vijay Gulya, Aasif Usmani, Mohd Usmani, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100CT2009PLC021430
- Company No.
021430
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Oct 2009
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Chhattisgarh
Industry
Company Details
- Location
Raipur, Chattisgarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Maverick Medichain?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Gulya  | Director | 04-Mar-2023 | Current |
| Aasif Usmani | Director | 02-Jun-2021 | Current |
| Mohd Usmani | Additional Director | 02-Jun-2021 | Current |
| Amninder Buttar | Director | 02-Jun-2021 | Current |
Financial Performance of Maverick Medichain.
Maverick Medichain Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 1.63% increase. The company also saw a slight improvement in profitability, with a 5.1% increase in profit. The company's net worth moved up by a moderate rise of 0.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maverick Medichain?
In 2021, Maverick Medichain had a promoter holding of 44.19% and a public holding of 55.81%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eduworth Clothings And Accessories Private LimitedActive 8 years 5 monthsVijay Gulya is a mutual person
- Maverick Activations Private LimitedActive 10 years 9 months
Aasif Usmani, Mohd Usmani and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Maverick Medichain?
Unlock and access historical data on people associated with Maverick Medichain, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maverick Medichain, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maverick Medichain's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
